DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Referenz

Glund S, Moschetti V, Norris S. et al.
A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran.

Thromb Haemost 2015;
113: 943-951.

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: